細(xì)胞形態(tài):淋巴樣
運(yùn)輸方式:凍存運(yùn)輸
年限:29 years
生長(zhǎng)狀態(tài):懸浮生長(zhǎng)
ATCC Number:CCL-113?
器官來(lái)源:外周血
相關(guān)疾病:淋巴瘤
數(shù)量:大量
是否是腫瘤細(xì)胞:1
物種來(lái)源:人
規(guī)格:100 ul Designations: RPMI 6666
Depositors: ?GE Moore
Biosafety Level:2 [Cell contain Herpesvirus ]
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Homo sapiens
Morphology:lymphoblast
Source: Organ: peripheral blood
Disease: Hodgkin's disease; Hodgkin's lymphoma
Cellular Products:immunoglobulin
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Antigen Expression:HLA A2, A3, B7, B18
Age: 29 years
Gender: male
Ethnicity: Caucasian
Comments:EBNA positive.
Biological Safety CLASS II.
Propagation: ATCC complete growth medium: RPMI 1640 medium, 80%; fetal bovine serum, 20%
Subculturing: Medium Renewal: Add fresh medium (10% to 20% by volume) every 3 to 4 days
Cultures can be maintained by the addition of fresh medium or replacement of medium. Establish new cultures at 5 X 10 exp5 viable cells/ml.
References: 22317: Moore GE, et al. Leukocyte cultures of patients with leukemia and lymphomas. N.Y. State J. Med. 66: 2757-2764, 1966. PubMed: 5232150